Welcome to Institutional Biosafety
The Institutional Biosafety Committee (IBC) is appointed by the Office of the Vice President for Research (OVPR) to ensure oversight by facilitating review of research involving recombinant DNA (rDNA) and synthetic nucleic acid molecules, infectious agents and other hazardous biological agents being conducted at, or sponsored by, Temple University.
Since Temple University receives funding from the National Institutes of Health (NIH) for rDNA/synthetic nucleic acid research, we are required to establish and register an Institutional Biosafety Committee (IBC) with the NIH Office of Science Policy (OSP) in assurance with the NIH Guidelines for Research involving rDNA/synthetic nucleic acid and meet other applicable regulations and standards.
OVPR is responsible for ensuring that the policies and directives of the IBC are enforced.
Helpful Links
Biosafety and Biosecurity
-
Toxins: Experiments involving the deliberate formation of recombinant or synthetic nucleic acid molecules containing genes for the biosynthesis of toxin molecules lethal for vertebrates at an LD50 of less than 100 nanograms per kilogram of body weight (see Section III-B of the NIH Guidelines)
-
Major Actions: The deliberate transfer of a drug resistance trait to a microorganism when such resistance could compromise the ability to control the disease agent in humans, veterinary medicine, or agriculture (see Section III-A-1-a of the NIH Guidelines)
-
Guidelines for handling human material (Clinical BRF Guide)
-
Animal Experiments
-
Stem Cell Information
-
Incident Reporting
-
Dual Use of Research Concern Guidance (DURC)
Getting Started
Access Flowchart, Forms & Standard Operating Procedures (SOPs)